KPIs & Operating Metrics(New)
Growth Metrics

Tenet Healthcare (THC) Cost of Revenue (2016 - 2026)

Tenet Healthcare (THC) has disclosed Cost of Revenue for 18 consecutive years, with $961.0 million as the latest value for Q1 2026.

  • For Q1 2026, Cost of Revenue fell 11.83% year-over-year to $961.0 million; the TTM value through Mar 2026 reached $4.0 billion, down 13.58%, while the annual FY2025 figure was $3.8 billion, 15.85% down from the prior year.
  • Cost of Revenue hit $961.0 million in Q1 2026 for Tenet Healthcare, down from $1.0 billion in the prior quarter.
  • Across five years, Cost of Revenue topped out at $1.8 billion in Q4 2024 and bottomed at $811.0 million in Q2 2022.
  • Average Cost of Revenue over 5 years is $1.0 billion, with a median of $942.0 million recorded in 2022.
  • Year-over-year, Cost of Revenue soared 90.66% in 2024 and then plummeted 43.1% in 2025.
  • Tenet Healthcare's Cost of Revenue stood at $1.0 billion in 2022, then fell by 9.79% to $931.0 million in 2023, then skyrocketed by 90.66% to $1.8 billion in 2024, then tumbled by 43.1% to $1.0 billion in 2025, then fell by 4.85% to $961.0 million in 2026.
  • According to Business Quant data, Cost of Revenue over the past three periods came in at $961.0 million, $1.0 billion, and $1.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.